Clinical Trials Directory

Trials / Completed

CompletedNCT04207450

Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment

Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment: a Triple-blind Randomized Clinical Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Universidade Federal do Para · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This randomized, placebo-controlled, triple-blind trial aims to evaluate the effect of glutaraldehyde associated or not with 37% phosphoric acid conditioning on dentin hypersensitivity reduction after non-surgical periodontal treatment, and its durability after 15 and 30 days. desensitizing treatment. Additionally, investigate the impact of these treatments on health-related quality of life. The investigators selected patients who, after scraping and planing procedures, presented at least 2 teeth meeting the following inclusion criteria: presence of gingival recession without or with a periodontal pocket up to 5mm probing depth, which presented painful sensitivity response to tactile stimulus. and evaporative. Subjects were randomized into 3 groups: Placebo Group (GP) - Placebo Gel application followed by Placebo solution (distilled water); GPG- Placebo Gel application followed by application 5% aqueous glutaraldehyde solution; GSG - Application of 37% phosphoric acid followed by 5% aqueous glutaraldehyde solution. The sensitivity of the dental elements was evaluated by pain stimuli (tactile and evaporative) with the aid of a Visual Analog Scale (VAS). A questionnaire was applied to patients with the objective of capturing psychosocial experiences, prior to treatment and one month after its completion, to assess the impact of desensitizing treatment on health-related quality of life. Data will be collected and appropriate statistical tests will be applied.

Conditions

Interventions

TypeNameDescription
OTHERPlacebo gelPlacebo gel application followed by placebo solution application (distilled water)
OTHERPlacebo Gel + 5% Glutaraldehyde Aqueous SolutionPlacebo gel followed by 5% aqueous glutaraldehyde solution
OTHERPhosphoric Acid 37% + Solução aquosa de glutaraldeído a 5%37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution

Timeline

Start date
2019-03-15
Primary completion
2019-11-29
Completion
2019-12-13
First posted
2019-12-20
Last updated
2020-04-21

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04207450. Inclusion in this directory is not an endorsement.